journal article·2022-08

Size and surface charge effect of layered double hydroxide particles upon blood cells

Tetsuo Yamaguchi, Hyoung-Mi Kim, Byung Chul Jung, Yoon Suk Kim, Jae-Min Oh

Publisher page

Abstract

Biological behavior of layered double hydroxide (LDH) toward human blood cells was evaluated with respect to the particle size and surface charge parameters. Three kinds of LDHs with different particle sizes were prepared by different synthesis routes and surface charge of the LDH was controlled by coating with citrate, malate or serine. Powder X-ray diffraction patterns and scanning electron microscopic (SEM) analyses indicated that the three LDHs before surface coating had average diameter ~ 160 nm, ~ 340 nm and ~ 1980 nm with well-crystallized hydrotalcite-like structure. According to zeta potential measurement, the surface coating with citrate, malate, and serine gave controlled zeta potential of −15.28 mV, 5.68 mV, and 36.5 mV, respectively. It was confirmed that all the six LDH samples regardless of size and surface charge did not induce serious hemolysis toward human red blood cells (RBCs), of which the value was less than 2.5% even in a high administration concentration of 10 mg/mL. However, the LDH with the largest size showed statistically a higher hemolysis ratio than the others at the high administration dose and long exposure time. The SEM showed that the large LDH particles induced membrane disruption by direct attack, while most of the LDH particles were softly landed on the RBC surface. Comparative SEM study suggested that the membrane interaction of LDH toward RBC was different from that with adherent cells. The adherent cells showed massive attachment of LDH particles on membrane periphery with active endocytosis. It was therefore concluded that LDH particles with moderate size are highly compatible to human blood cells.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Polymer Surface Interaction Studies · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (66)

Show source-provided references
1. Effect of different forms of anionic nanoclays on cytotoxicity10.1166/jnn.2011.3408 ↗
2. 2006
3. Doxil® - the first FDA-approved nano-drug: Lessons learned10.1016/j.jconrel.2012.03.020 ↗
4. Nanomedicine
5. Layered double hydroxide-based nanocarriers for drug delivery10.3390/pharmaceutics6020298 ↗
6. Millisecond-timescale, genetically targeted optical control of neural activity10.1038/nn1525 ↗
7. Biodegradable 2D Fe–Al hydroxide for nanocatalytic tumor-dynamic therapy with tumor specificity10.1002/advs.201801155 ↗
8. Layered double hydroxide nanoparticles as target-specific delivery carriers: Uptake mechanism and toxicity10.2217/nnm.11.86 ↗
9. Effect of physico-chemical parameters on the toxicity of inorganic nanoparticles10.1039/c1jm10167f ↗
10. Cellular toxicity of inorganic hydroxide nanoparticles10.1166/jnn.2007.18081 ↗
11. Safety aspect of inorganic layered nanoparticles: Size-dependency in vitro and in vivo10.1166/jnn.2008.1143 ↗
12. Biocompatible ceramic nanocarrier for drug delivery with high efficiency10.2109/jcersj2.117.543 ↗
13. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells10.1016/j.jinorgbio.2008.12.017 ↗
14. Anticancer drug encapsulated in inorganic lattice can overcome drug resistance10.1039/b925831k ↗
15. Drug-ceramic 2-dimensional nanoassemblies for drug delivery system in physiological condition10.1111/j.1551-2916.2012.05219.x ↗
16. Emerging nanomaterials with advanced drug delivery functions; focused on methotrexate delivery10.1016/j.ccr.2018.01.007 ↗
17. Inorganic-biomolecular hybrid nanomaterials as a genetic molecular code system10.1002/adma.200400027 ↗
18. Clay minerals and layered double hydroxides for novel biological applications10.1016/j.clay.2006.07.007 ↗
19. Accessing the biocompatibility of layered double hydroxide by intramuscular implantation: Histological and microcirculation evaluation10.1038/srep30547 ↗
20. The hemocompatibility of nanoparticles: A review of cell–nanoparticle interactions and hemostasis10.3390/cells8101209 ↗
21. Interaction of gold nanoparticles with common human blood proteins10.1021/nn9011187 ↗
22. Interactions between biological cells and layered double hydroxides: towards functional materials10.1002/tcr.201700102 ↗
23. Antibody-targeted drug delivery to injured arteries using layered double hydroxide nanoparticles10.1002/adhm.201200069 ↗
24. Far-field optical nanoscopy10.1126/science.1137395 ↗
25. Preparation and evaluation of well-defined hemocompatible layered double hydroxide-poly(sulfobetaine) nanohybrids10.1039/c2jm32720a ↗
26. Intercalation of functional organic molecules with pharmaceutical, cosmeceutical and nutraceutical functions into layered double hydroxides and zinc basic salts
27. Ceramic layered double hydroxide nanohybrids for therapeutic applications10.1007/s43207-020-00090-5 ↗
28. Intracrystalline structure and release pattern of ferulic acid intercalated into layered double hydroxide through various synthesis routes10.1016/j.clay.2015.04.015 ↗
29. Nano-bio interaction between graphite oxide nanoparticles and human blood components10.1002/ejic.201200587 ↗
30. Inorganic nanomedicines and their labeling for biological imaging10.2174/1568026611313040009 ↗
31. Hematocompatibility and interaction of layered double hydroxide nanomaterials with plasma proteins10.1166/sam.2014.1838 ↗
32. Surface treatment of silica nanoparticles for stable and charge-controlled colloidal silica
33. Size- and surface charge-controlled layered double hydroxides for efficient algal flocculation10.1039/C7EN00809K ↗
34. 1975
35. Inorganic delivery vector for intravenous injection10.1016/j.biomaterials.2004.01.056 ↗
36. Layered double hydroxide nanoparticles in gene and drug delivery10.1517/17425240903130585 ↗
37. Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles10.1016/j.biomaterials.2013.06.046 ↗
38. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts10.1021/am200428v ↗
39. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity10.1021/ja910846q ↗
40. Magnetic mesoporous silica microspheres with thermo-sensitive polymer shell for controlled drug release10.1039/b902985k ↗
41. Adsorption of amphiphilic hyperbranched polyglycerol derivatives onto human red blood cells10.1016/j.biomaterials.2010.01.021 ↗
42. Graphene and graphene oxide as new nanocarriers for drug delivery applications10.1016/j.actbio.2013.08.016 ↗
43. Multidentate zwitterionic chitosan oligosaccharide modified gold nanoparticles: Stability, biocompatibility and cell interactions10.1039/c3nr00284e ↗
44. Clay minerals: Properties and applications to dermocosmetic products and perspectives of natural raw materials for therapeutic purposes—a review10.1016/j.ijpharm.2017.10.031 ↗
45. Engineering biofunctional magnetic nanoparticles for biotechnological applications10.1039/c0nr00104j ↗
46. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: Enhanced efficacy due to clathrin-mediated endocytosis10.1021/bc0601323 ↗
47. Inorganic drug-delivery nanovehicle conjugated with cancer-cell-specific ligand10.1002/adfm.200801127 ↗
48. Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis10.1002/asia.200800290 ↗
49. Park · 2006
50. Biodegradable inorganic nanovector: passive versus active tumor targeting in siRNA transportation10.1002/anie.201510844 ↗
51. Facile formation of dendrimer-stabilized gold nanoparticles modified with diatrizoic acid for enhanced computed tomography imaging applications10.1039/c2nr31687k ↗
52. Room temperature synthesis of highly hemocompatible hydroxyapatite, study of their physical properties and spectroscopic correlation of particle size10.1039/c0nr00611d ↗
53. Zirconium phosphate nanoplatelets: a biocompatible nanomaterial for drug delivery to cancer10.1039/c3nr34242e ↗
54. Multifunctional Fe3O4 core/Ni-Al layered double hydroxides shell nanospheres as labels for ultrasensitive electrochemical immunoassay of subgroup J of avian leukosis virus10.1016/j.bios.2012.04.035 ↗
55. Chelator-free labeling of layered double hydroxide nanoparticles for in Vivo PET imaging10.1038/srep16930 ↗
56. Cancer nanomedicine: Progress, challenges and opportunities10.1038/nrc.2016.108 ↗
57. The improved stability of molecular guests by the confinement into nanospaces10.1246/cl.181026 ↗
58. Computer simulation study of the structural stability and materials properties of DNA-intercalated layered double hydroxides10.1021/ja077679s ↗
59. Size-dependent effects of layered double hydroxide nanoparticles on cellular functions of mouse embryonic stem cells10.2217/nnm.15.158 ↗
60. Layered double hydroxide nanoparticles promote self-renewal of mouse embryonic stem cells through the PI3K signaling pathway10.1039/C5NR02339D ↗
61. Subcellular compartment targeting of layered double hydroxide nanoparticles10.1016/j.jconrel.2008.05.021 ↗
62. Periodic charge matching driven immobilization of gentamicin in nanoclays for stable and long-term antibacterial coating10.1039/D1DT02540F ↗
63. Efficient transdermal penetration and improved stability of L-ascorbic acid encapsulated in an inorganic nanocapsule10.5012/bkcs.2003.24.4.499 ↗
64. Drug–clay nanohybrids as sustained delivery systems10.1016/j.clay.2016.01.021 ↗
65. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects10.2174/138161210791920496 ↗
66. Acute oral toxicity and kinetic behaviors of inorganic layered nanoparticles10.1155/2013/628381 ↗